A team of scientists at the Yale Schools of Medicine and Public Health has identified a remdesivir-resistant variant of SARS-CoV-2, the virus that causes COVID-19, in an immunocompromised patient who was being treated with ...
Mar 23, 2022
0
131
Spare a thought for patients with impaired immunity during the COVID-19 pandemic. Their condition puts them at high risk of severe complications from COVID-19, but also creates uncertainty about the safety and effectiveness ...
Mar 17, 2022
0
10
Some of the same researchers at The University of Texas at Austin who created a key to all coronavirus vaccines used in the U.S. have made a similar advance against the human metapneumovirus (hMPV), one of a handful of remaining ...
Mar 14, 2022
0
90
Additional doses of COVID-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, say experts in The BMJ today.
Mar 2, 2022
0
10
It's relatively rare to be hospitalized after getting vaccinated against COVID-19, but those who do typically have significant health issues that contribute to their risk.
Feb 17, 2022
0
7
As the U.S. enters its third year of the pandemic, COVID-19 cases are at an all-time high thanks to the highly transmissible omicron variant.
Jan 5, 2022
0
11
On Wednesday, the U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which protects against COVID-19, discovered ...
Dec 13, 2021
0
4
A real-world retrospective cohort study involving nearly 1.2 million people shows COVID-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems.
Nov 30, 2021
0
89
In what could be very good news for the immunocompromised, an antibody cocktail tested at the University of Virginia School of Medicine appears to offer long-lasting protection from COVID-19.
Nov 12, 2021
0
76
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows immunocompromised patients using rituximab (a drug used to treat diseases like rheumatoid arthritis) were able ...
Nov 2, 2021
0
9
